Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

Pharmacokinetic Models: Comparison and Selection Criterion

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

Pharmacokinetic Models: Overview

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...

Pharmacodynamic Models: Overview

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Health literacy focused communication training for primary healthcare providers working with older adults: A scoping review.

Geriatric nursing (New York, N.Y.)·2025

Same author

Feasibility of identifying proliferative active bone marrow with fat fraction MRI and multi-energy CT.

Physics in medicine and biology·2024

Same author

Multiple interventions following an acute coronary syndrome event increase uptake into cardiac rehabilitation.

International journal of cardiology·2020

Same author

An evaluation of community-based cognitive stimulation therapy: a pilot study with an Irish population of people with dementia.

Irish journal of psychological medicine·2018

Same author

SU-E-T-137: The Response of TLD-100 in Mixed Fields of Photons and Electrons.

Medical physics·2017

Same author

Screening for asymptomatic urogenital Chlamydia trachomatis infection at a large Dublin maternity hospital: results of a pilot study.

Irish journal of medical science·2016

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

QSAR in the pharmaceutical research setting: QSAR models for broad, large problems.

D G Sprous¹, R K Palmer, J T Swanson

¹Redpoint Bio., Ewing NJ, USA. dsprous@redpointbio.com

Current Topics in Medicinal Chemistry

|March 27, 2010

Summary

Quantitative structure-activity relationship (QSAR) models are essential for drug discovery, aiding chemists with property predictions and lead optimization. This review covers QSAR fundamentals, focusing on large datasets and 2D descriptors for pharmaceutical research.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Related Experiment Videos

Last Updated: Jun 14, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Area of Science:

Computational Chemistry
Medicinal Chemistry
Chemoinformatics

Background:

Quantitative structure-activity relationships (QSAR) are integral to pharmaceutical discovery.
QSAR models are used routinely for predicting properties like logP and metabolic stability.
Advanced QSAR is employed for lead optimization and designing compound libraries against specific targets.

Purpose of the Study:

To provide a comprehensive review of QSAR methodologies in pharmaceutical research.
To focus on large dataset approaches (≥100 compounds) and 2D descriptors.
To cover QSAR fundamentals, including data, descriptors, equations, and validation.

Main Methods:

Review of established QSAR applications for logP, pKa/pKb, and metabolic stability.
Discussion of methodologies for larger datasets and 2D descriptors.
Exploration of emerging QSAR models for hERG liability, drug-likeness, kinase, and GPCR ligand likeness.

Main Results:

QSAR success relies on appropriate mathematics linking valid data and relevant descriptors.
Routine QSAR applications provide invisible yet crucial support for bench chemists.
Active development is ongoing for advanced QSAR models in areas of broad interest.

Conclusions:

Effective QSAR model validation and understanding performance are crucial for originators.
The review covers foundational QSAR principles and progresses to cutting-edge applications.
QSAR continues to be a vital and evolving tool in modern drug discovery.